BenevolentAI Investor Day Presentation Deck

Benevolent • Investment Highlights Market leader in Al drug discovery with scientifically and technologically differentiated approach Significant platform scale and internal capability Rich portfolio of drug programmes all generated from the Benevolent Platform™ High-value and successful commercial partnership proving strategic validation Robust IP with patents on drug pipeline and copyright and trade secrets on our technology platform Flexible business model with revenue opportunities to extend cash runway Near and medium-term key value inflection points World-renowned Board and experienced leadership team Benevolent 72

View entire presentation